A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting β2-agonists in allergic asthmatic patients

Chest

Volumn 119, Issue 5, 2001, Pages 1306-1315

  Cloosterman, Sonja G M ^a   Bijl Hofland, Ingrid D ^a   van Herwaarden, Cees L A ^a   Akkermans, Reinier P ^a   van den Elshout, Frank J J ^b   Folgering, Hans T M ^a   van Schayck, Constant P ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Allergens; Allergic asthma; Bronchial hyperresponsiveness; Tolerance; 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FENOTEROL; FORMOTEROL; HISTAMINE; HOUSE DUST ALLERGEN; IPRATROPIUM BROMIDE; LONG ACTING DRUG; PLACEBO; PREDNISONE; SALBUTAMOL;

ALLERGIC ASTHMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUST EXPOSURE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MITE; MONOTHERAPY; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; REGULATORY MECHANISM; SPIROMETRY; TREATMENT OUTCOME;

EID: 0034939360     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.5.1306     Document Type: Article

References (44)

1. Circumstances surrounding the deaths of children due to asthma
2. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: A further case-control study
3. The use of β-agonists and the risk of death and near death from asthma
4. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline
5. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline
6. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol
7. Bronchodilator treatment in moderate asthma or chronic bronchitis: Continuous or on demand? A randomised controlled study
8. Regular inhaled β-agonist treatment in bronchial asthma
9. Inhaled formoterol during 1-year in asthma: A comparison with salbutamol
10. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma
11. 2-agonists in asthma
12. Regular inhaled salbutamol and airway responsiveness to allergen
13. Regular use of inhaled albuterol and the allergen-induced late asthmatic response
14. How detrimental is chronic use of bronchodilators in asthma and chronic obstructive pulmonary disease?
15. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease
16. Bronchial responsiveness during regular fenoterol therapy: Four months prospective study
17. 2-agonist salmeterol in mild to moderate asthmatic patients
18. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
19. Added salmeterol versus higher-dose corticosteroids in asthma patients with symptoms on existing inhaled corticosteroids
20. Effects of the long-acting β agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids
21. 2-agonists: Is there cause for concern?
22. Effects of house-dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house-dust mite allergic asthmatic patients, using no inhaled steroids
23. Accuracy, precision and linearity of the portable flow-volume meter Microspiro HI-298
24. Airway responsiveness: Standardized challenge testing with pharmacologic, physical and sensitizing stimuli in adults
25. Psychophysical bases of perceived exertion
26. Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma
27. Lung volumes and forced ventilatory flows
28. 2-agonist treatment
29. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients
30. 2-agonists
31. Clinical pharmacology of long-acting β-receptor agonists
32. Regular formoterol treatment in mild asthma: Effect on bronchial responsiveness during and after treatment
33. Salmeterol tachyphylaxis in steroid treated asthmatic subjects
34. Effect of inhaled formoterol and budesonide on exacerbations of asthma
35. 2-adrenergic receptors in vivo
36. Differential effect of formoterol on adenosine activity in asthma
37. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma
38. Bronchodilator effect of inhaled formoterol vs salbutamol > 12 hours
39. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness > 24 hours in bronchial asthma
40. Rebound airway obstruction and responsiveness after cessation of terbutaline: Effects of budesonide
41. Potential masking effects of salmeterol on airway inflammation in asthma
42. House dust mite allergen avoidance: A randomized controlled trial of surface chemical treatment and encasement of bedding
43. The effects of a single treatment of an acaricide, Acarosan, and a detergent, Metsan, on Der p I allergen levels in the carpets and mattresses of asthmatic children